Daniel Lighezan

6.3k total citations
70 papers, 510 citations indexed

About

Daniel Lighezan is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Daniel Lighezan has authored 70 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Daniel Lighezan's work include Blood Pressure and Hypertension Studies (15 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Cardiovascular Health and Disease Prevention (8 papers). Daniel Lighezan is often cited by papers focused on Blood Pressure and Hypertension Studies (15 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Cardiovascular Health and Disease Prevention (8 papers). Daniel Lighezan collaborates with scholars based in Romania, United States and France. Daniel Lighezan's co-authors include Roxana Buzaș, Doina Georgescu, Maria Dorobanţu, Ioana Ioniță, Oana-Florentina Tautu, Cătălina Arsenescu Georgescu, Cristina Tudoran, Roxana Darabont, Florin Mitu and Călin Pop and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Daniel Lighezan

66 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Lighezan Romania 13 197 77 60 58 57 70 510
В. В. Лихванцев Russia 13 209 1.1× 128 1.7× 37 0.6× 80 1.4× 106 1.9× 122 809
Ali Osman Yıldırım Türkiye 14 103 0.5× 151 2.0× 31 0.5× 93 1.6× 79 1.4× 67 562
Tomasz Zapolski Poland 13 186 0.9× 65 0.8× 50 0.8× 39 0.7× 58 1.0× 50 409
Konika Sharma United States 16 185 0.9× 156 2.0× 141 2.4× 58 1.0× 107 1.9× 27 619
Alastair Gillies Australia 12 128 0.6× 81 1.1× 118 2.0× 44 0.8× 41 0.7× 31 435
Gülendam Koçak Türkiye 12 138 0.7× 65 0.8× 32 0.5× 59 1.0× 61 1.1× 41 420
Remy J.H. Martens Netherlands 14 200 1.0× 81 1.1× 197 3.3× 27 0.5× 100 1.8× 24 622
Μaria Bonou Greece 12 271 1.4× 95 1.2× 27 0.5× 24 0.4× 106 1.9× 62 625
Ovidiu Mitu Romania 13 246 1.2× 72 0.9× 18 0.3× 36 0.6× 52 0.9× 76 479
Mark Flemmer United States 8 105 0.5× 172 2.2× 39 0.7× 63 1.1× 81 1.4× 28 614

Countries citing papers authored by Daniel Lighezan

Since Specialization
Citations

This map shows the geographic impact of Daniel Lighezan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lighezan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lighezan more than expected).

Fields of papers citing papers by Daniel Lighezan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lighezan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lighezan. The network helps show where Daniel Lighezan may publish in the future.

Co-authorship network of co-authors of Daniel Lighezan

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lighezan. A scholar is included among the top collaborators of Daniel Lighezan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lighezan. Daniel Lighezan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lighezan, Daniel, et al.. (2025). History of Heart Failure Definition. Cardiac failure review. 11. e07–e07. 2 indexed citations
3.
Negru, Alina Gabriela, et al.. (2025). Clinical Significance of TAPSE/PASP Ratio in Risk Stratification for Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of Cardiovascular Development and Disease. 12(12). 468–468. 1 indexed citations
5.
Lighezan, Daniel, et al.. (2025). Relationship Between Depression and Decreased Activity Level and Cognitive Impairment in Patients with Diabetes Mellitus Type 2 and/or Atrial Fibrillation. Journal of Clinical Medicine. 14(2). 563–563. 2 indexed citations
7.
Lighezan, Daniel, et al.. (2024). The Family Doctor in the “COVID-19 Era”. Healthcare. 13(1). 32–32.
8.
Lighezan, Daniel, et al.. (2024). Factors Influencing the Development and Severity of Cognitive Decline in Patients with Chronic Heart Failure. Medicina. 60(11). 1859–1859. 4 indexed citations
9.
Cirin, Liviu, Simina Crișan, Roxana Buzaș, et al.. (2024). Mitral Annular Plane Systolic Excursion (MAPSE): A Review of a Simple and Forgotten Parameter for Assessing Left Ventricle Function. Journal of Clinical Medicine. 13(17). 5265–5265. 6 indexed citations
10.
Lighezan, Daniel, et al.. (2024). Connections between Cognitive Impairment and Atrial Fibrillation in Patients with Diabetes Mellitus Type 2. Biomedicines. 12(3). 672–672. 15 indexed citations
11.
Buzaș, Roxana, et al.. (2024). Correlation of the FIB-4 Liver Biomarker Score with the Severity of Heart Failure. Medicina. 60(12). 1943–1943. 1 indexed citations
12.
Georgescu, Doina, et al.. (2023). Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?. International Journal of General Medicine. Volume 16. 3889–3906. 10 indexed citations
13.
Sharma, Abhinav, et al.. (2023). Rhythm Disturbances in Post-Acute COVID-19 Syndrome in Young Men without Pre-Existing Known Cardiovascular Disease—A Case Series. Biomedicines. 11(4). 1146–1146. 8 indexed citations
14.
Şoica, Codruţa, et al.. (2023). Lacticaseibacillus rhamnosus—A Promising Tool for Colorectal Cancer Treatment. Processes. 11(3). 781–781. 2 indexed citations
15.
Georgescu, Doina, et al.. (2023). NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden. Life. 14(1). 25–25. 2 indexed citations
16.
Sharma, Abhinav, et al.. (2023). Prevalence of Cardio-Embolic Brain Complications in Permanent and Paroxysmal Atrial Fibrillation Patients. Healthcare. 11(2). 175–175. 5 indexed citations
17.
Georgescu, Doina, et al.. (2022). Dyspepsia and Gut Microbiota in Female Patients with Postcholecystectomy Syndrome. SHILAP Revista de lepidopterología. 13 indexed citations
18.
Pînzaru, Iulia, Daniel Lighezan, Codruţa Şoica, et al.. (2022). A Combination of Two Probiotics, Lactobacillus sporogenes and Clostridium butyricum, Inhibits Colon Cancer Development: An In Vitro Study. Microorganisms. 10(9). 1692–1692. 18 indexed citations
19.
Șirli, Roxana, Ioan Sporea, Simona Bota, et al.. (2014). Contrast Enhanced Ultrasound in the pathology of the pancreas – a monocentric experience.. Medical Ultrasonography. 16(4). 325–31. 12 indexed citations
20.
Frent, Stefan, et al.. (2014). Sensitivity and specificity of neck circumference in obstructive sleep apnea syndrome. European Respiratory Journal. 44(Suppl 58). P2293–P2293. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026